… understanding of coronavirus disease 2019 (COVID-19) … characterized by increased tumor
necrosis factor α (TNF-α), interleukin (… of targeting the TNF-α pathway in COVID-19 treatment. …

… -19 morbidity and mortality. In addition, this review … of TNF-α as a biomarker for the prognosis
of severe COVID-19 and its related complications and as a molecular target for anti-TNF-α …

… (TEN) and COVID-19, we hypothesize that the application of etanercept, an inhibitor of
TNFα, could attenuate disease progression in severe group COVID-19 patients by suppressing …

… over the course of COVID-19. We report the case of a recovery from COVID-19 in a 60- year-
… tumour necrosis factor- alpha (TNF-α) inhibitor (the soluble TNF receptor: etanercept 50 mg, …

… and severe COVID-19 complications and the association of A allele with high TNF-α production,
… to assess the validity of TNF-α G-308 A promoter polymorphism in COVID-19 patients. …

… between inflammatory diseases with COVID-19, we meta-analyzed and integrated tissue-level
single-cell profiles from five inflammatory diseases and COVID-19. We created an …

… higher TNF-α … COVID-19 is TNF-α/TNF receptor 1–dependent through immune mechanisms
that may contribute to lymphopenia. TNF-α blockade may be beneficial in severe COVID-19. …

… The current COVID-19 pandemic revealed also unexpected … anti-TNF-α agents [17]; anti-TNF-α
use protects against severe COVID-19 infection and hospitalization due to COVID-19 and …

… patients with IBD and COVID-19 spontaneously inserted by … of COVID-19 is lower in patients
in treatment with anti-TNF-α … patients with COVID-19 in treatment with anti-TNF-α needed …

… anti–tumor necrosis factor α … against COVID-19 started in Israel on December 19, 2020, with
mRNA-based … for the efficacy and safety of the COVID-19 BNT162b2 vaccine in patients with …